ARTICLES LIST

 

Total Results: 16203

Media ID Source Name Media Type Language Media Name Media Description Keywords Keywords Link to Article
1424 National Cancer Institute Html en Liver (Hepatocellular) Cancer Screening (PDQ®)–Health Professional Version Expert-reviewed information summary about tests used to detect or screen for liver (hepatocellular) cancer.
positive predictive value0.503935
Needle aspiration cytology0.492344
10-year survival rates0.485559
hepatitis B virus0.608203
hepatitis G infection0.516552
control group0.576587
6-monthly AFP assays0.575205
North America0.429041
nonalcoholic steatohepatitis0.42282
AFP screening0.526835
usual-care group0.429439
ethnic groups0.421496
test result0.419937
HCC0.942449
screening group0.63461
Age-standardized incidence rates0.541219
hepatitis B infection0.498394
glycogen storage disease0.517803
porphyria cutanea tarda0.523911
new cases0.427232
patients experience pain0.502381
Serum AFP0.49956
fetal-specific glycoprotein antigen0.51455
United States0.614175
screening tests0.450593
retrospective case-control study0.516703
mortality rate ratio0.509505
certain Aspergillus species0.510442
widely used tumor0.501438
cryptogenic cirrhosis0.452869
earlier diagnosis0.555097
right upper quadrant0.485875
common cancer0.432709
surface antigen–positive carriers0.524371
diagnosis study designs.0.509206
Chinese Americans0.422068
high incidence0.419907
distinct male preponderance0.54002
risk factor0.421115
HCC mortality0.712636
mortality rate0.512472
randomized controlled trial0.492498
alcoholic cirrhosis0.45216
chronic hepatitis0.816099
germ cell tumors0.509004
liver biopsy0.576034
annual risk0.42449
liver cancer0.48682
CLICK HERE
1453 National Cancer Institute Html en Esophageal Cancer Prevention (PDQ®)–Health Professional Version Expert-reviewed information summary about factors that may influence the risk of developing esophageal cancer and about research aimed at the prevention of this disease.
population-based case-controlled study0.456088
Incidence rates0.385333
symptomatic gastroesophageal reflux0.449595
Barrett epithelium0.458468
control group0.467545
population attributable risk0.450158
abnormal intestinal-type epithelium0.466177
upper gastrointestinal hemorrhage0.4271
GERD symptoms0.44816
dysplastic Barrett esophagus0.622479
distal esophagus0.516913
case-control studies0.466408
characteristic endoscopic appearance0.435919
racial/ethnic groups0.387576
alcohol abuse0.441548
sham ablation0.397202
patients0.529714
incidence rate0.442768
relative risk0.448332
long-standing GERD0.393778
esophageal adenocarcinoma0.436843
esophageal adenocarcinoma.0.389793
Retrospective cohort studies0.444668
radiofrequency ablation0.397459
new cases0.385134
population-based cohort study0.450776
esophageal cancer0.543708
United States0.381547
neoplastic alteration0.380441
squamous epithelium.0.390253
Barrett esophagus0.930056
disease progression0.441468
low-grade dysplasia0.40734
significantly increased risk0.448898
recurrent reflux symptoms0.445059
important epidemiological difference0.443496
black men0.381968
case-control study0.397548
high-grade dysplasia group0.469185
adenocarcinoma0.464553
certain GERD symptoms0.4422
risk factor0.383382
randomized controlled trial0.433019
treatment group0.414938
stratified squamous epithelium0.484787
ablation group0.497322
risk0.45334
columnar epithelium0.407571
CLICK HERE
1562 National Cancer Institute Html en Hypopharyngeal Cancer Treatment (PDQ®)–Patient Version Expert-reviewed information summary about the treatment of hypopharyngeal cancer.
cancer treatment0.321266
high-dose radiation therapy0.323579
centimeters0.269921
cancer spreads0.270417
malignant tumor cells0.281954
body0.305644
chemotherapy0.290118
PDQ cancer information0.346817
stage III hypopharyngeal0.274417
clinical trial search0.347149
clinical trials0.698171
hypopharynx0.280224
cancer information summary0.319294
metastatic hypopharyngeal cancer0.310093
clinical trial0.551798
Recurrent hypopharyngeal cancer0.306668
patients0.317052
stage IV hypopharyngeal0.274937
nearby soft tissue0.271159
treatment clinical trial0.275593
NCI PDQ cancer0.283768
radiation therapy0.705932
Treatment Editorial Board0.281401
General information0.289657
hypopharyngeal cancer0.722179
general cancer information0.275426
treatment0.442202
new cancer treatments0.272872
NCI-supported cancer0.296123
cancer cells0.361641
Cancer Information Service0.276024
patient0.26688
lymph nodes0.350794
treatment clinical trials0.300384
National Cancer Institute0.364736
swollen lymph nodes0.277694
new treatment0.302418
External radiation therapy0.314938
neck0.309398
cancer research process0.269057
cancer clinical trials0.358746
stage0.310003
neck cancer0.286172
lymph node0.322344
cancer information summaries0.27414
comprehensive cancer information0.274558
cancer0.901171
standard treatment0.274055
Hypopharyngeal Cancer Treatment0.314822
CLICK HERE
1664 National Cancer Institute Html en Childhood Central Nervous System Atypical Teratoid/Rhabdoid Tumor Treatment (PDQ®)–Patient Version Expert-reviewed information summary about the treatment of childhood atypical teratoid/rhabdoid tumors
cancer treatment0.542006
metastatic brain tumors0.391418
ongoing clinical trials0.389415
PDQ cancer information0.511527
tumor suppressor genes0.452709
clinical trial search0.399694
brain tumors0.444671
CNS atypical teratoid/rhabdoid0.388691
clinical trials0.847224
Pediatric Treatment Editorial0.416481
Teratoid/Rhabdoid Tumor Treatment0.445097
cancer information summary0.463674
clinical trial0.521041
cancer cells0.510172
stem cell transplant0.396934
patients0.411179
primary brain tumors0.3918
treatment clinical trial0.409064
NCI PDQ cancer0.42324
radiation therapy0.555658
Treatment Editorial Board0.420841
Cord Tumors Treatment0.414346
late effects0.393798
treatment0.689522
new cancer treatments0.395428
PDQ treatment summary0.447943
childhood brain0.385451
Cancer Information Service0.399251
specific cancer cells0.397642
PDQ Pediatric Treatment0.40786
treatment clinical trials0.444124
National Cancer Institute0.458723
spinal cord0.616147
tumor cells0.437516
effects cancer treatment0.421518
new treatment0.427513
childhood cancer information0.400212
External radiation therapy0.395094
brain tumor0.405279
brain0.467984
atypical teratoid/rhabdoid tumor0.982554
PDQ summary0.439127
cancer clinical trials0.434177
cancer information summaries0.39809
comprehensive cancer information0.397631
cancer0.740574
appropriate cancer treatment0.419383
standard treatment0.391688
fast-growing tumor0.388774
CLICK HERE
1883 National Cancer Institute Html es Tratamiento de los tumores extracraneales de células germinativas en la niñez (PDQ®)–Versión para profesionales de salud Resumen de información revisada por expertos acerca del tratamiento de los tumores extracraneales de células germinativas en la niñez.
cell tumor protocols0.408279
germinativas malignas localización0.405353
células germinativas seminomatosos.Seminoma0.410393
cell tumor combined0.407867
germ cell tumours0.412186
Perlman EJ0.405253
Calaminus G0.412513
Cell Cancer Collaborative0.406794
cell tumors from0.406747
Göbel U0.406021
Cancer Group0.42074
cell tumor studies0.407558
pediatric oncology0.41388
células germinativas mixtos0.417539
International Germ Cell0.417008
Children's Oncology Group0.409014
mediastinal germ0.406328
cell tumor study0.408368
<2 cm0.405406
Metástasis peritoneales macroscópicas0.405941
germ cell neoplasms0.406391
Children's Cancer0.42175
cell tumors show0.406094
pediatric germ0.426106
adultos jóvenes0.40725
estadio iv0.405826
ganglios linfáticos ≥20.411723
Germ Cell Consensus0.412507
Cushing B0.405386
teratomas benignos0.407141
Genes Chromosomes Cancer0.438953
with germ0.406335
malignant germ cell0.462527
PDQ Tratamiento0.405882
childhood germ0.409831
cell tumors based0.405903
Clin Oncol0.444548
saco vitelino0.435575
linfáticos ≥2 cm0.408554
Schneider DT0.409517
Children's Cancer Group0.419331
Cell Consensus Classification0.409901
germ cell tumors0.974328
Kingdom Children Cancer0.408316
germ cell cancer0.410294
Children's Cancer Study0.409136
pediatric oncology group0.410202
oncology group0.420408
Cancer Study Group0.411644
CLICK HERE
2000 National Cancer Institute Html es Tratamiento de la histiocitosis de células de Langerhans (PDQ®)–Versión para pacientes Resumen de información revisada por expertos acerca del tratamiento de la histiocitosis de células de Langerhans.
cuánto aire0.415134
siguientes procedimientos0.528715
células madre0.858073
adultos jóvenes0.464664
efectos secundarios meses0.439126
siguientes aspectos0.434701
faja ajustadora0.428231
HCL infantil multisistémica0.546722
cuántos sistemas0.518567
genes ras0.453948
pequeña cantidad0.423844
células normales.ampliar exploración0.532323
vía oral0.42013
rayos x0.425227
gen braf0.666188
largo plazo0.44968
cuántas células0.518957
niño ayuda0.426203
efectos tardíos0.516221
escáner.ampliar exploración0.429231
tarde.ampliar ecografía0.427113
vías respiratorias0.424871
causa problemas0.424997
lesiones óseas0.423193
National Cancer Institute0.417904
IRMN).Ampliar Imágenes0.421648
siguientes riesgos0.415861
radiación uvb0.414555
Instituto Nacional0.431398
PDQ Tratamiento0.451873
antecedentes familiares0.589915
llamada genes ras0.432872
explorador tep0.430081
terapia fotodinámica causa0.453098
sistema nervioso central0.604707
Physician Data Query0.464236
mayores probabilidades0.416225
HCL multisistémica0.966875
terapia fotodinámica llamada0.451949
radiación ultravioleta0.561342
siguientes pruebas0.489919
CLICK HERE
2036 National Cancer Institute Html es Tratamiento de las neoplasias mieloproliferativas crónicas (PDQ®)–Versión para pacientes Resumen de información revisada por expertos acerca del tratamiento de las neoplasias mieloproliferativas crónicas.
siguientes procedimientos0.417826
células madre0.649424
siguientes aspectos0.405563
leucemia aguda0.417682
cuerpo.ampliar trasplante0.403016
hueso compacto0.418199
genes mpl0.404719
enlace drugs approved0.416336
célula madre mieloide0.431519
genes jak20.404899
Sudores nocturnos0.404299
células anormales.ampliar aspiración0.420044
National Cancer Institute0.401966
siguientes riesgos0.401801
Instituto Nacional0.403647
célula madre linfoide0.432844
PDQ Tratamiento0.431983
leucemia mielógena0.471893
Drugs Approved0.417258
Physician Data Query0.407937
llamada mielofibrosis0.427648
serios problemas0.403469
Myeloproliferative Neoplasms0.417257
siguientes sustancias0.403598
policitemia vera0.696975
leucemia mieloide aguda0.414565
gen jak20.405058
célula madre0.501376
células sanguíneas maduras0.468721
neoplasias mieloproliferativas0.925417
siguientes pruebas0.407534
CLICK HERE
3518 National Cancer Institute Html en Use of Placebos Information about placebos and their role in cancer clinical trials.
new treatment0.545554
study0.364583
patients0.362034
medicine0.367624
way0.414648
treatment group0.529513
to.0.361225
doctors0.371883
treatment clinical trials0.815475
bias0.382394
Placebos0.570523
standard treatment0.968379
cancer0.37398
CLICK HERE
3676 National Cancer Institute Html en Genomic Data Access Information for NIH staff and extramural investigators on how to get a dbGaP account and how to request controlled-access data.
Supplementary Instructions0.508326
trainees0.351501
data use limitations0.53645
access request form0.751577
permanent employees0.518968
cancer genotype-phenotype studies0.653287
dbgap datasets0.7932
Laboratory staff0.513494
dbGaP Project Request0.758272
Minimum Qualifications0.520392
institution0.370914
staff member0.507438
database0.339571
oversight0.341561
responsibilities0.337646
Extramural investigators0.646629
postdoctoral fellows0.532793
eRA Commons0.541518
Applicants0.337875
laboratory administration0.514783
data access request0.968754
NIH staff0.519235
PIs0.358599
tenure-track professor0.518153
NCI Data Access0.741329
signature approvals0.518117
Eligibility requirements0.511168
results0.339375
email0.333649
dbGaP Authorized Access0.761069
seniorscientist0.335515
Access Individual-Level Data0.77002
principal investigators0.705009
genotypes0.422884
pre-existing account0.549785
data access requests0.732725
dbGaP Request Procedures0.709981
graduate students0.515113
phenotypes0.420428
DAR0.341157
access permission form0.755217
project requests0.50912
Investigators Requesting Authorized0.770653
interaction0.333238
access form0.569266
online0.337555
CLICK HERE
15640 National Cancer Institute Html null Research & Development (R&D) Contracts null
CLICK HERE

 

 

 

Terms of Use | Privacy Policy
©2017 ARCHES Technology. All Rights Reserved.